AU3807499A - Pharmaceutical tablets comprising cefuroxime axetil - Google Patents

Pharmaceutical tablets comprising cefuroxime axetil

Info

Publication number
AU3807499A
AU3807499A AU38074/99A AU3807499A AU3807499A AU 3807499 A AU3807499 A AU 3807499A AU 38074/99 A AU38074/99 A AU 38074/99A AU 3807499 A AU3807499 A AU 3807499A AU 3807499 A AU3807499 A AU 3807499A
Authority
AU
Australia
Prior art keywords
cefuroxime axetil
pharmaceutical tablets
tablets
pharmaceutical
axetil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38074/99A
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3807499A publication Critical patent/AU3807499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU38074/99A 1998-05-29 1999-05-18 Pharmaceutical tablets comprising cefuroxime axetil Abandoned AU3807499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2239331 1998-05-29
CA 2239331 CA2239331C (en) 1998-05-29 1998-05-29 Pharmaceutical tablets comprising cefuroxime axetil
PCT/CA1999/000446 WO1999062559A1 (en) 1998-05-29 1999-05-18 Pharmaceutical tablets comprising cefuroxime axetil

Publications (1)

Publication Number Publication Date
AU3807499A true AU3807499A (en) 1999-12-20

Family

ID=4162505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38074/99A Abandoned AU3807499A (en) 1998-05-29 1999-05-18 Pharmaceutical tablets comprising cefuroxime axetil

Country Status (3)

Country Link
AU (1) AU3807499A (en)
CA (1) CA2239331C (en)
WO (1) WO1999062559A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT413647B (en) 1998-11-26 2006-04-15 Sandoz Ag USE OF A COPOLYMERISATE OF 1-VINYL-2-PYRROLIDONE AND VINYL ACETATE FOR THE PREPARATION OF CEFUROXIMAXETIL-SUBJECTED TABLETS
ES2291433T3 (en) * 2002-03-04 2008-03-01 Orbus Pharma Inc. COMPOSITIONS OF CEFUROXIMA AXETILO DE LIBERACION RAPIDA.
WO2005002540A2 (en) * 2003-07-01 2005-01-13 Ranbaxy Laboratories Limited Dry powder pharmaceutical suspension compositions of cefuroxime axetil
KR100552567B1 (en) * 2003-08-23 2006-02-15 한국유나이티드제약 주식회사 Formulation of stable for moisture absorption and quickly dissolved tablet containing cefuroxime axetil and it's manufacturing process
GB0400971D0 (en) * 2004-01-16 2004-02-18 Sandoz Ag Pharmaceutical compositions
CN104230957B (en) * 2013-06-09 2017-02-08 广东立国制药有限公司 Preparing method of cefuroxime acid and method of removing DCC lactone in preparation process of the cefuroxime acid
CN106109433A (en) * 2016-08-10 2016-11-16 瑞阳制药有限公司 CEFUROXIME AXETIL Film coated tablets and preparation method thereof
CN114191375B (en) * 2021-12-20 2022-07-26 广东金城金素制药有限公司 Cefuroxime sodium for injection and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
ES525492A0 (en) * 1982-09-10 1985-02-01 Glaxo Group Ltd A PROCEDURE FOR THE PRODUCTION OF A HERMETICALLY CLOSED CONTAINER CONTAINING AT LEAST ONE BETA-LACTAMA ANTIBIOTIC.
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil

Also Published As

Publication number Publication date
WO1999062559A1 (en) 1999-12-09
CA2239331C (en) 1999-11-30

Similar Documents

Publication Publication Date Title
AU1071301A (en) Pharmaceutical compounds
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU3567700A (en) Signal processing
AU5259100A (en) Medicament
AU1278701A (en) Novel compounds
AU2270101A (en) Pharmaceutical kit
AU3571400A (en) Detergent tablet
AU1409100A (en) Drugs
AU8591898A (en) Pharmaceutical compounds
AU2449000A (en) Signal processing means
AU4330097A (en) Pharmaceutical compounds
AU3807499A (en) Pharmaceutical tablets comprising cefuroxime axetil
AU2692200A (en) Enteral sorbefacients
AU1645700A (en) Oenothein medicaments
AUPP388298A0 (en) Precursers of pharmaceutical compounds
AU8995998A (en) Pacifier
AU5722900A (en) Pharmaceutical compounds
AU6480299A (en) Pharmaceutical compounds
AU4169897A (en) Pharmaceutical compounds
AUPP332898A0 (en) Pharmaceutical composition
AU1688099A (en) Pharmaceutical preparation
AU2359301A (en) Novel ss-defensins
AU3862100A (en) Detergent tablet
AU2109700A (en) Novel compounds
AU4914400A (en) Novel pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase